PTX Pernix Therapeutics Holdings, Inc.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pernix Therapeutics Holdings, Inc. market cap is $403,400.00.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Pernix Therapeutics Holdings, Inc. 52 week high is $2.65 as of May 18, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pernix Therapeutics Holdings, Inc. 52 week low is $0.017 as of May 18, 2024.

Pernix Therapeutics Holdings, Inc. stock price today is $0.0289.

Pernix Therapeutics Holdings, Inc. stock price yesterday was $0.0213.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pernix Therapeutics Holdings, Inc.’s P/E ratio is None.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pernix Therapeutics Holdings, Inc. P/B ratio is -0.0020.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Pernix Therapeutics Holdings, Inc.'s EBITDA is 184.36.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pernix Therapeutics Holdings, Inc. 50-day moving average is $0.0254.

Pernix Therapeutics Holdings, Inc. has N/A employees.